Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Adolescents Who Previously Received Novartis MenACWY Conjugate Vaccine or Commercially Available MenACWY Conjugate Vaccine

NCT00856297 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT00856297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Adolescents Who Previously Received Novartis MenACWY Conjugate Vaccine or Commercially Available MenACWY Conjugate Vaccine
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2009
Completion date
November 30, 2012
Enrollment
389 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal meningitis